Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Doxycycline
Lavet Pharmaceuticals Ltd
QJ01AA02
Doxycycline
Expired
Revised: 22 September 2008 AN: 00572/2008 1.B. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Ladoxyn 500 mg/g granules for oral solution for pigs _(in Cyprus, Czech Republic, Denmark, Greece, Hungary, Portugal and Spain)_ Pulmodox 500 mg/g granules for oral solution for pigs _(in Austria, France, Germany, Italy, Slovakia and United Kingdom)_ 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One g granules for oral solution contains: ACTIVE SUBSTANCE: Doxycycline (as hyclate) 500.0 mg EXCIPIENTS: lactose monohydrate For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Granules for oral solution. Yellow, free-flowing granules. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs (fattening pigs after weaning). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of clinical respiratory infections in pigs caused by _Mycoplasma hyopneumoniae_ and _Pasteurella multocida_ susceptible to doxycycline. 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of the excipients. Do not use when tetracycline resistance has been detected in the herd due to the potential for cross resistance. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES The uptake of medication by animals can be altered as a consequence of illness. In case of insufficient uptake of drinking water, animals should be treated parenterally. Revised: 22 September 2008 AN: 00572/2008 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Inappropriate use of the product may increase the prevalence of bacteria resistant to tetracycline due to the potential for cross resistance. Use of the product should be based on susceptibility testing and take into account official and local antimicrob Read the complete document